Prostate cancer: open trials in Finland

• NCT06136624

  Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Kuopio University Hospital, Kuopio · Tampere University Hospital, Tampere · Turku University Hospital, Turku

  Registry updated 2026-11-05

• NCT06629779

  A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

  Trial Treatment · Phase 3 · Pfizer

  HUS-Yhtymae, Helsinki · Kuopio University Hospital, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku

  Registry updated 2026-10-30

• NCT07262619

  EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

  Trial Treatment · Phase 1/2 · Eikon Therapeutics

  Kuopio University Hospital, Kuopio

  Registry updated 2026-10-30

• NCT07344779

  A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice

  Research · Bayer

  Many Locations, Many Locations

  Registry updated 2026-10-19

• NCT07611110

  AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

  Trial Treatment · Phase 3 · AstraZeneca

  Kuopio

  Registry updated 2026-10-19

• NCT06952803

  A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  Trial Treatment · Phase 3 · AstraZeneca

  HUS-Yhtymae, Helsinki · Docrates Oy, Helsinki · Kuopio University Hospital, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku

  Registry updated 2026-10-14

• NCT07028853

  This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  Trial Treatment · Phase 3 · Pfizer

  Docrates Oy, Helsinki · HUS-Yhtymae, Helsinki · Kuopio University Hospital, Kuopio · Oulu University Hospital, Oulu · Tampere University Hospital, Tampere · Turku University Hospital, Turku · Vaasa Central Hospital, Vaasa

  Registry updated 2026-10-14

• 2024-517854-91-00

  Impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy

  Trial Treatment · Phase 3 · Pirkanmaan hyvinvointialue

  HUS-Yhtymae, Helsinki · Central Finland Hospital District Central Finland Hospital Nova, Jyvaskyla · Etelae-Pohjanmaan hyvinvointialue, Seinajoki · Tampere University Hospital, Tampere · Turku University Hospital, Turku

  Registry updated 2026-10-08

• 2023-504704-28-00

  Transdermal estradiol and exercise in mitigating adverse effects of androgen deprivation therapy for prostate cancer radiation therapy (ESTRACISE)

  Trial Treatment · Phase 2 · Varsinais-Suomen hyvinvointialue

  Central Finland Hospital District Central Finland Hospital Nova, Jyvaskyla · University Of Jyvaskyla, Jyvaskyla · Tampere University Hospital, Tampere · Varsinais-Suomen hyvinvointialue, Turku

  Registry updated 2026-10-07

• NCT05448547

  Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer

  Trial Treatment · Phase 3 · Sven Löffeler

  Helsinki University Hospital, Helsinki · Tampere University Hospital, Tampere · Turku University Hospital, Turku

  Registry updated 2026-09-10

• NCT07740239

  A COhort Study on Factors Leading to Vulnerability in Adult Patients With Serious Medical cOnditionS: the COSMOS-I Trial

  Research · Tampere University Hospital

  Tampere University Hospital, Tampere

  Registry updated 2026-07-31

• NCT06217822

  First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

  Trial Treatment · Phase 1 · Bayer

  Mehilaeinen Oy, Helsinki · HUS-Yhtymae, Helsinki · Pohjois-Savon hyvinvointialue, Kuopio · Tampere University Hospital, Tampere · Turku University Hospital, Turku

  Registry updated 2026-07-07

• 2024-515109-24-00

  Measuring Oncological Value of Exercise and Statin (MOVES)

  Trial Treatment · Phase 3 · Pirkanmaan hyvinvointialue

  Pirkanmaan hyvinvointialue, Tampere

  Registry updated 2026-05-21

• NCT07369570

  Evolution of Lesions in Repeated Biparametric Prostate Magnetic Resonance Imaging

  Trial Treatment · University of Eastern Finland

  Kuopio University Hospital, Kuopio

  Registry updated 2026-02-24

• NCT05796973

  Measuring Oncological Value of Exercise and Statin

  Trial Treatment · Phase 3 · Tampere University Hospital

  Tampere University Hospital, Tampere

  Registry updated 2025-06-27

• NCT03423303

  A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen)

  Trial Treatment · Tampere University

  Helsinki University and Helsinki University Hospital, Helsinki · University of Tampere, Tampere

  Registry updated 2025-04-17

• NCT03903835

  ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer

  Trial Treatment · Phase 3 · Karolinska Institutet

  HUS-Yhtymae, Helsinki

  Registry updated 2025-04-09

• NCT06850545

  Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer

  Research · Kuopio University Hospital

  Kuopio University Hospital, Kuopio

  Registry updated 2025-02-27

• NCT03876912

  The effect of androgen deprivation therapy on the expression of prostate specific membrane antigen (PSMA) in treatment naive metastatic prostate cancer

  Trial Treatment · Phase 2 · Turku University Hospital

  Turku University Hospital, Turku

  Registry updated 2025-01-28

• 2024-511104-16-00

  Molecular theranostics for metastatic prostate cancer: PSMA, FAPI, or both?

  Trial Treatment · Phase 2 · Turku University Hospital

  Turku University Hospital, Turku

  Registry updated 2024-02-28

• NCT06219746

  99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate Cancer

  Trial Treatment · Phase 2/3 · Turku University Hospital

  Turku University Hospital, Turku

  Registry updated 2024-01-23

• NCT06001619

  Prostate Medication, Metabolism and Gut Microbiota

  Trial Treatment · Phase 4 · Turku University Hospital

  Turku University Hospital, Turku · University Of Turku, Turku

  Registry updated 2023-08-21

• 2022-500618-24-00

  Prostate medication, metabolism and gut microbiota, PROMED.

  Trial Treatment · Phase 4 · Turku University Central Hospital

  Turku University Central Hospital, Turku

  Registry updated 2022-10-04

• NCT02102477

  Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer

  Trial Treatment · Olof Akre

  Helsinki University Hospital, Department of Urology, Helsinki · Tampere University Hospital, Pihlajalinna Koskiklinikka, Tampere · Turku University Hospital, Turku

  Registry updated 2022-03-31

• NCT04287088

  bpMRI and Risk Based Shared Clinical Decision Making in Prostate Cancer Diagnosis

  Trial Treatment · Turku University Hospital

  Central Finland Central Hospital, Jyväskylä · Satakunta Central Hospital, Pori · Tampere University Hospital, Tampere · Turku University Hospital, Turku

  Registry updated 2021-11-23

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error